tirzepatide device Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA Tirzepatide | DirectMeds

Tirzepatide, a dual GLP-1 and GIP receptor agonist, addresses this cardiovascular threat through two interconnected mechanisms: sustained weight loss and direct improvements in arterial flexibility and heart workload

They primarily work by mimicking a gut hormone that slows digestion, reduces appetite, and improves insulin secretion

Research compilation on how different macronutrients affect metabolic rate and energy expenditure

All vials include batch-specific Certificates of Analysis (COA) to support experimental documentation and reproducibility

Common side effects may include nausea, diarrhoea, decreased appetite, vomiting, constipation, indigestion, and stomach pain

In this blog, well take a closer look at how these medications work, who can benefit from them, and what you can expect when starting treatment at Alchemy Wellness